BAT's 'Return to Algorithm' Is a Choosy One — Funding a Multi-Category Land Grab in the US
Smokeless hits 19.8% of revenue, EPS guidance raised to mid-single digits, yet management deliberately guides the top line to the low end to fund Velo Max, Vuse flavors, and glo Hilo.
BTI · Earnings Call · 2026-07-30
The Algorithm Nuance
Tadeu Marroco opened by framing the moment: “Smokeless now represents 19.8% of group revenue, up 160 basis points versus last year.” — Tadeu Marroco, CEO · 2026-07-30 — a transformation milestone as BAT positions itself as a total-nicotine company rather than a cigarette maker. But the more revealing line was the deliberate posture on full-year guidance:
We are here thinking about the long-term sustainability of the algorithm... we position in the low end to create us the possibility to make the right investments to make this a sustainable story moving forward.
Management is guiding revenue and operating profit to the low end of the midterm algorithm — the 3–5% revenue / 4–6% operating-profit framework laid out in February. H1 came "in line with expectations," and Javed Iqbal confirmed the group is "on track to return to our midterm algorithm for the full year." The deliberate low-end guidance is the real story: after two years of reset and investment, BAT is choosing to fund a multi-category offensive — Velo Max, Vuse flavor pods, scaling glo Hilo, and increased US combustible investment — rather than chase the top of the range.
That said, EPS guidance was actually raised: "we now expect full year EPS growth to be towards the middle of our 5% to 8% range." Javed was candid on the current-currency view: “once we take into account the FX impact, our adjusted EPS would be in the range of 4%, 4.5%, which is just for a reminder, is one of the best EPS performance of BAT in recent years.” — Syed Iqbal, Interim CFO · 2026-07-30 That kicker is driven below the operating line — lower net finance costs after repaying debt with the partial ITC disposal proceeds in May 2025 — plus >95% cash conversion.
Is the US Combustible Surge Real?
The most pointed analyst challenge hit US combustibles: revenue up 5% in H1 versus the long-term framework of flattish to +1% value growth. Tadeu answered with unusual directness:
“I will tell you that this equates for something close to 2% of the 5%... so underlying performance actually is more of a 3%. Clearly, we have a momentum in the H1. Duty drawback is part of the 3%, but it's not a major part of it.” — Tadeu Marroco, CEO · 2026-07-30
So roughly 40% of H1's headline US cigarette growth is favorable inventory timing that reverses in H2 — management expects H2 US numbers to moderate "much closer to the algorithm, maybe a bit still higher than the 0 to 1." BAT is leaning on Duty drawback and trade inventory as bridges while it rebuilds share momentum. Volume share has been "held since January" despite "heightened competitive activity since Q4 last year," with targeted investment behind Newport, Camel, Lucky Strike, and Pall Mall Select.
The structural worry remains tax-driven: industry cigarette volume guidance was cut to −3%, now “basically Brazil-driven. We had a massive excise shock in Brazil.” — Tadeu Marroco, CEO · 2026-07-30 — a fresh headwind that supersedes, and in part replaces, the Bangladesh narrative of prior quarters.
The US Vape Door Reopens
What genuinely changed this quarter is regulatory. The FDA's prioritization guidance gives legal manufacturers a pathway to bring scientifically backed flavors to market — and BAT moved fast: a "phased rollout of new adult focused Vuse flavors... starting in Q3 with distribution to approximately 25,000 outlets." This is the first real opening for legal US vape since the 2021 flavor ban. Tadeu was measured on a competitor's Modern Oral modified-risk grant: “It's more about the advocacy of the category... even outside the U.S.” — Tadeu Marroco, CEO · 2026-07-30 — while confirming BAT's own Velo MRTPA applications are pending. The tailwind also lifts Vuse Ultra, with value share at a record 55.9%.
The flip side is strategic retreat elsewhere: “we decide to pull out of a number of markets that we have entered in the first place when they have regulated with an expectation that regulation would be made compliant. This was not the case.” — Tadeu Marroco, CEO · 2026-07-30 A GBP 149 million credit from settling historical litigation (the Canada chapter reaching the P&L) helped H1 EPS.
Costs, Cash, and the Smokeless Engine
Fit2Win has grown teeth: management now targets "GBP 700 million of annualized savings by 2028 with GBP 500 million to be delivered by 2027," with one-off costs of GBP 950 million (mostly non-cash, including a ~GBP 230 million charge for the manufacturing-technology review). Category contribution jumped 55% at constant rates to GBP 269 million on the back of disciplined investment, and cash conversion stayed "above 95%." Leverage is guided back inside the 2–2.5x corridor by year-end, protecting the progressive dividend and the GBP 1.3 billion buyback.
The February call laid the foundation — a "3% revenue, 5% revenue, leading to a 4% to 6% operating profit" algorithm with 2026 framed as a reinvestment year: “there will be years where we're going to reinvest back in the business at the back of exciting innovations. And 2026 is one of these years.” — Tadeu Marroco, Chief Executive Officer · 2026-02-12 This quarter delivers the payoff: smokeless at ~20% of revenue, Velo Plus at roughly 31% volume share in US Modern Oral capturing "around 90% of category value growth," and glo Hilo "beginning to demonstrate the benefits of our premiumization strategy."
Notably, BAT is absent from the IEEPA/tariff-refund tailwind many consumer peers are booking this quarter — its lever is regulatory (FDA pathway, state enforcement) and cost (Fit2Win), not trade policy. That contrast underscores how idiosyncratic this story is.
Bottom line: BAT is executing a two-front transition — defending cigarette cash flow with price/mix and duty drawback while pouring proceeds into Velo, Vuse, and glo. The risk: if US combustible growth moderates as guided and APMEA's recovery stays "slower than expected" (illicit volumes in Bangladesh and Australia, regulatory pressure), the raised EPS guidance hinges on the smokeless engine firing on all cylinders. September's Capital Markets Day will be the first real test of whether this "return to algorithm" is durable — or a one-year squeeze.